RxDoctor Payments Data

Riley Worth

Family · Sandy, UTNPI 1447966841

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $895,706 of the $1,104,587 with a category attached, or 81.1%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $523,072, 2.1 times the $251,865 reported in 2023. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,104,587in general payments, 2019–2025

Across 1,430 payments — averaging $772.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.1M
  • Revance Therapeutics, Inc.$308

What the payments were for

  • Consulting fees$19,0982%
  • Speaking & faculty fees$895,70681%
  • Travel & lodging$167,43415%
  • Food & beverage$22,2702%
  • Education$780%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1,426$1,104,279
Revance Therapeutics, Inc.4$308

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,104,587 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Other family in Sandy

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →